PortfoliosLab logoPortfoliosLab logo
HEI-A vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HEI-A vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HEICO Corporation (HEI-A) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HEI-A achieves a -2.07% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, HEI-A has outperformed NVO with an annualized return of 24.98%, while NVO has yielded a comparatively lower 7.56% annualized return.


HEI-A

1D
-1.58%
1M
12.98%
YTD
-2.07%
6M
2.08%
1Y
4.12%
3Y*
23.55%
5Y*
13.77%
10Y*
24.98%

NVO

1D
-0.18%
1M
-6.80%
YTD
-10.74%
6M
-9.50%
1Y
-43.34%
3Y*
-15.59%
5Y*
2.92%
10Y*
7.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HEI-A vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HEI-A
HEICO Corporation
-2.07%35.80%30.81%19.03%-6.60%9.94%30.98%42.21%24.78%45.72%
NVO
Novo Nordisk A/S
-10.74%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between HEI-A and NVO is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2016

0.18

Fundamentals

Market Cap

HEI-A:

$34.85B

NVO:

$195.21B

EPS

HEI-A:

$5.60

NVO:

DKK 27.42

PE Ratio

HEI-A:

44.13

NVO:

10.34

PEG Ratio

HEI-A:

1.99

NVO:

0.44

PS Ratio

HEI-A:

7.09

NVO:

3.85

PB Ratio

HEI-A:

6.46

NVO:

6.21

Total Revenue (TTM)

HEI-A:

$4.91B

NVO:

DKK 327.80B

Gross Profit (TTM)

HEI-A:

$943.00M

NVO:

DKK 268.30B

EBITDA (TTM)

HEI-A:

$1.12B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HEI-A vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HEI-A
HEI-A Risk / Return Rank: 4545
Overall Rank
HEI-A Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
HEI-A Sortino Ratio Rank: 4343
Sortino Ratio Rank
HEI-A Omega Ratio Rank: 4242
Omega Ratio Rank
HEI-A Calmar Ratio Rank: 4747
Calmar Ratio Rank
HEI-A Martin Ratio Rank: 4646
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HEI-A vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HEICO Corporation (HEI-A) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HEI-ANVODifference
Sharpe ratioReturn per unit of total volatility

+0.97

Sortino ratioReturn per unit of downside risk

+1.49

Omega ratioGain probability vs. loss probability

1.05

0.85

+0.20

Calmar ratioReturn relative to maximum drawdown

0.15

-0.80

+0.95

Martin ratioReturn relative to average drawdown

0.35

-1.18

+1.53

HEI-A vs. NVO - Sharpe Ratio Comparison

The current HEI-A Sharpe Ratio is 0.13, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of HEI-A and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HEI-A vs. NVO - Drawdown Comparison

The maximum HEI-A drawdown since its inception was -49.70%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for HEI-A and NVO.


Loading charts...

Drawdown Indicators


HEI-ANVODifference

Max Drawdown

Largest peak-to-trough decline

-49.70%

-74.70%

+25.00%

Max Drawdown (1Y)

Largest decline over 1 year

-27.11%

-54.34%

+27.23%

Max Drawdown (3Y)

Largest decline over 3 years

-27.11%

-74.70%

+47.59%

Max Drawdown (5Y)

Largest decline over 5 years

-27.11%

-74.70%

+47.59%

Max Drawdown (10Y)

Largest decline over 10 years

-49.70%

-74.70%

+25.00%

Current Drawdown

Current decline from peak

-10.52%

-68.11%

+57.59%

Average Drawdown

Average peak-to-trough decline

-7.67%

-17.79%

+10.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.75%

37.62%

-25.87%

Volatility

HEI-A vs. NVO - Volatility Comparison

HEICO Corporation (HEI-A) has a higher volatility of 15.25% compared to Novo Nordisk A/S (NVO) at 10.68%. This indicates that HEI-A's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HEI-ANVODifference

Volatility (1M)

Calculated over the trailing 1-month period

15.25%

10.68%

+4.57%

Volatility (6M)

Calculated over the trailing 6-month period

24.87%

38.04%

-13.17%

Volatility (1Y)

Calculated over the trailing 1-year period

31.49%

51.88%

-20.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.68%

38.33%

-10.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.60%

32.56%

-1.96%

Dividends

HEI-A vs. NVO - Dividend Comparison

HEI-A's dividend yield for the trailing twelve months is around 0.10%, less than NVO's 4.11% yield.


PositionTTM20252024202320222021202020192018201720162015
HEI-A
HEICO Corporation
0.10%0.09%0.11%0.14%0.15%0.13%0.14%0.08%0.18%0.10%0.25%0.00%
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

HEI-A vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between HEICO Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
1.38B
96.82B
(HEI-A) Total Revenue
(NVO) Total Revenue
Please note, different currencies. HEI-A values in USD, NVO values in DKK

HEI-A vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between HEICO Corporation and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-40.0%-20.0%0.0%20.0%40.0%60.0%80.0%20222023202420252026
-33.1%
86.0%
Portfolio components
HEI-A - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HEICO Corporation reported a gross profit of -454.96M and revenue of 1.38B. Therefore, the gross margin over that period was -33.1%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

HEI-A - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HEICO Corporation reported an operating income of 350.44M and revenue of 1.38B, resulting in an operating margin of 25.5%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

HEI-A - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HEICO Corporation reported a net income of 233.80M and revenue of 1.38B, resulting in a net margin of 17.0%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


HEI-A and NVO have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HEI-A has higher volatility (15.25%) compared to NVO (10.68%). In terms of maximum drawdown, HEI-A dropped -49.70% vs NVO's -74.70%.

HEI-A currently has the higher Sharpe Ratio (0.13 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HEI-A and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer